⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15022 | 1.00 | — | — | |
| Ethylene SCHEMBL20454806 | 0.93 | — | — | |
| SCHEMBL4439080 | 0.93 | — | — | |
| SCHEMBL60109 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL9726137 | 0.93 | — | — | |
| SCHEMBL4440883 | 0.93 | — | — | |
| SCHEMBL4448885 | 0.93 | — | — | |
| Ammonia Solution, Strong SCHEMBL3791290 | 0.93 | — | — | |
| SCHEMBL4450502 | 0.93 | — | — | |
| SCHEMBL1472728 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10280183-B2 | Therapeutic agent for treating tumors | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2019-05-07 | — | — | US | disclosed |
| US-20170166591-A1 | THERAPEUTIC AGENT FOR TREATING TUMORS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2017-06-15 | — | — | US | disclosed |
| WO-2015143092-A1 | THERAPEUTIC AGENT FOR TREATING TUMORS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2015-09-24 | — | — | WO | disclosed |
| US-20120010233-A1 | METHODS AND COMPOSITIONS TO INHIBIT EDEMA FACTOR AND ADENYLYL CYCLASE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS (US) | 2012-01-12 | — | — | US | disclosed |
| US-8003692-B2 | Methods and compositions to inhibit edema factor and adenylyl cyclase | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-08-23 | — | — | US | disclosed |
| EP-2166841-A2 | METHODS AND COMPOSITIONS TO INHIBIT EDEMA FACTOR AND ADENYLYL CYCLASE | Mission Pharmacal Company (US) | 2010-03-31 | — | — | EP | disclosed |
| US-20090275782-A1 | Quantum Dots Tailored with Electronically-Active Polymers | NATIONAL SCIENCE FOUNDATION | 2009-11-05 | — | — | US | disclosed |
| US-7589240-B2 | Quantum dots tailored with electronically-active polymers | UNIVERSITY OF MASSACHUSETTS (US) | 2009-09-15 | — | — | US | disclosed |
| US-20090093519-A1 | Methods and Compositions to Inhibit Edema Factor and Adenylyl Cyclase | MISSION PHARMACAL CO. (US) | 2009-04-09 | — | — | US | disclosed |
| WO-2009038842-A2 | METHODS AND COMPOSITIONS TO INHIBIT EDEMA FACTOR AND ADENYLYL CYCLASE | MISSION PHARMACAL CO. (US) | 2009-03-26 | — | — | WO | disclosed |
| WO-2006135387-A2 | QUANTUM DOTS TAILORED WITH ELECTRONICALLY-ACTIVE POLYMERS | UNIVERSITY OF MASSACHUSETTS (US) | 2006-12-21 | — | — | WO | disclosed |
| US-20060128845-A1 | Quantum dots tailored with electronically-active polymers | NATIONAL SCIENCE FOUNDATION | 2006-06-15 | — | — | US | disclosed |
| EP-0319900-B1 | FURYL, PHENYLENE AND THIENYL LEUKOTRIENE B4 ANALOGUES | G.D. Searle & Co. (US) | 1993-09-29 | — | — | EP | disclosed |
| US-4971997-A | ANTIINFLAMMATORY AGENTS, LEUKOTRIENES | G. D. SEARLE & CO. (US) | 1990-11-20 | — | — | US | disclosed |
| US-4970229-A | ANTIINFLAMMATORY AGENTS | G. D. SEARLE & CO. (US) | 1990-11-13 | — | — | US | disclosed |
| US-4970234-A | ANTIINFLAMMATORY AGENTS | G. D. SEARLE & CO. (US) | 1990-11-13 | — | — | US | disclosed |
| US-4962203-A | ANTIASTHMATIC, ANTIALLERGENIC, ANTIINFLAMMATORY AND CYTOPROTECTIVE AGENTS | MERCK FROST CANADA, INC. (CA) | 1990-10-09 | — | — | US | disclosed |
| US-4855324-A | ANTIINFLAMMATORY AGENTS | G. D. SEARLE & CO. (US) | 1989-08-08 | — | — | US | disclosed |
| EP-0319900-A2 | Furyl, phenylene and thienyl leukotriene B4 analogues | G.D. Searle & Co. (US) | 1989-06-14 | — | — | EP | disclosed |
| EP-0206751-A2 | 2-Substituted quinolines, their preparation and use | MERCK FROSST CANADA INC. (CA) | 1986-12-30 | — | — | EP | disclosed |